Retraction Note: HnRNP A1 - mediated alternative splicing of CCDC50 contributes to cancer progression of clear cell renal cell carcinoma via ZNF395
- DOI
- 10.1186/s13046-023-02613-4
- Published
- 2023-02-08
- Container
- Journal of Experimental & Clinical Cancer Research
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
serious concern Score 29/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- serious concernRetraction Watch retraction: 1 retraction notice matched this DOI.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1186/s13046-023-02613-4,
title = {Retraction Note: HnRNP A1 - mediated alternative splicing of CCDC50 contributes to cancer progression of clear cell renal cell carcinoma via ZNF395},
author = {Guoliang Sun and Hui Zhou and Ke Chen and Jin Zeng and Yangjun Zhang and Libin Yan and Weimin Yao and Junhui Hu and Tao Wang and Jinchun Xing and Kefeng Xiao and Lily Wu and Zhangqun Ye and Hua Xu},
year = {2023},
journal = {Journal of Experimental \& Clinical Cancer Research},
doi = {10.1186/s13046-023-02613-4},
url = {https://doi.org/10.1186/s13046-023-02613-4}
}RIS
TY - JOUR TI - Retraction Note: HnRNP A1 - mediated alternative splicing of CCDC50 contributes to cancer progression of clear cell renal cell carcinoma via ZNF395 AU - Guoliang Sun AU - Hui Zhou AU - Ke Chen AU - Jin Zeng AU - Yangjun Zhang AU - Libin Yan AU - Weimin Yao AU - Junhui Hu AU - Tao Wang AU - Jinchun Xing AU - Kefeng Xiao AU - Lily Wu AU - Zhangqun Ye AU - Hua Xu PY - 2023 JO - Journal of Experimental & Clinical Cancer Research DO - 10.1186/s13046-023-02613-4 UR - https://doi.org/10.1186/s13046-023-02613-4 ER -
APA
Sun, G., Zhou, H., Chen, K., Zeng, J., Zhang, Y., Yan, L., Yao, W., Hu, J., Wang, T., Xing, J., Xiao, K., Wu, L., Ye, Z., & Xu, H. (2023). Retraction Note: HnRNP A1 - mediated alternative splicing of CCDC50 contributes to cancer progression of clear cell renal cell carcinoma via ZNF395. Journal of Experimental & Clinical Cancer Research. https://doi.org/10.1186/s13046-023-02613-4
Source records
- crossref · retrieved 2026-09-27T08:16:39.041Z